Interleukin 6 Dependence of Anti-DNA Antibody Production: Evidence for Two Pathways of Autoantibody Formation in Pristane-induced Lupus

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1998 Sep 9

PMID 9730900

Citations 75

Authors

H B Richards

M Satoh

M Shaw

C Libert

V Poli

W H Reeves

Affiliations

Soon will be listed here.

Abstract

Pristane induces a lupus-like syndrome in nonautoimmune mice characterized by the development of glomerulonephritis and lupus-associated autoantibodies. This is accompanied by overproduction of interleukin (IL)-6, a cytokine linked with autoimmune phenomena. The goal of this study was to evaluate the role of IL-6 in autoantibody production in pristane-induced lupus. BALB/cAn IL-6-deficient (-/-) and -intact (+/+) mice were treated with pristane or phosphate-buffered saline, and autoantibody production was evaluated. Pristane induced high levels of immunoglobulin (Ig)G anti-single-stranded DNA, -double-stranded (ds)DNA, and -chromatin antibodies in IL-6(+/+), but not IL-6(-/-) mice by enzyme-linked immunosorbent assay. High titer IgG anti-dsDNA antibodies also were detected in sera from +/+, but not -/-, mice by Crithidia luciliae kinetoplast staining. The onset of IgG anti-dsDNA antibody production in +/+ mice occurred >5 mo after pristane treatment, well after the onset of nephritis, suggesting that these antibodies are not directly responsible for inducing renal disease. In contrast to anti-DNA, the frequencies of anti-nRNP/Sm and anti-Su antibodies were similar in pristane-treated IL-6(-/-) and IL-6(+/+) mice. However, levels were higher in the +/+ group. These results suggest that IgG anti-DNA and chromatin antibodies in pristane-treated mice are strictly IL-6 dependent, whereas induction of anti-nRNP/Sm and Su autoantibodies is IL-6 independent. The IL-6 dependence of anti-DNA, but not anti-nRNP/Sm, may have implications for understanding the patterns of autoantibody production in lupus. Anti-DNA antibodies are produced transiently, mainly during periods of disease activity, whereas anti-nRNP/Sm antibody levels are relatively insensitive to disease activity. This may reflect the differential IL-6 dependence of the two responses.

Citing Articles

Comparative time-series analyses of gut microbiome profiles in genetically and chemically induced lupus-prone mice and the impacts of fecal transplantation.

Chatthanathon P, Leelahavanichkul A, Cheibchalard T, Wilantho A, Hirankarn N, Somboonna N Sci Rep. 2024; 14(1):26371.

PMID: 39487198 PMC: 11530527. DOI: 10.1038/s41598-024-77672-4.

Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity.

Zhang Y, Morris R, Brown G, Lorenzo A, Meng X, Kershaw N J Exp Med. 2024; 221(4).

PMID: 38417019 PMC: 10901239. DOI: 10.1084/jem.20221080.

LncRNA promotes IL-6 secretion in monocyte-derived dendritic cells via sponging in systemic lupus erythematosus.

Xiang M, Wang Y, Chen Q, Wang J, Gao Z, Liang J Epigenetics. 2023; 18(1):2226492.

PMID: 37343193 PMC: 10286691. DOI: 10.1080/15592294.2023.2226492.

Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases.

Risso V, Lafont E, Le Gallo M Cell Death Dis. 2022; 13(3):248.

PMID: 35301281 PMC: 8931059. DOI: 10.1038/s41419-022-04688-x.

Metformin improves FOXP3 mRNA expression through suppression of interferon gamma levels in pristane-induced murine models of lupus.

Sumantri S, Hatta M, Natzir R, Rasyid H, Rengganis I, Massi M F1000Res. 2021; 9:342.

PMID: 34386197 PMC: 8327221. DOI: 10.12688/f1000research.23471.2.

References

Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F . Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci U S A. 1987; 84(1):228-31. PMC: 304176. DOI: 10.1073/pnas.84.1.228. View

Sontheimer R, Gilliam J . An immunofluorescence assay for double-stranded DNA antibodies using the Crithidia luciliae kinetoplast as a double-stranded DNA substrate. J Lab Clin Med. 1978; 91(4):550-8. View

Taga T, Kawanishi Y, Hardy R, Hirano T, Kishimoto T . Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression. J Exp Med. 1987; 166(4):967-81. PMC: 2188724. DOI: 10.1084/jem.166.4.967. View

Helfgott D, May L, Sthoeger Z, Tamm I, Sehgal P . Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts. J Exp Med. 1987; 166(5):1300-9. PMC: 2189663. DOI: 10.1084/jem.166.5.1300. View

Fisher C, Eisenberg R, Cohen P . Quantitation and IgG subclass distribution of antichromatin autoantibodies in SLE mice. Clin Immunol Immunopathol. 1988; 46(2):205-13. DOI: 10.1016/0090-1229(88)90183-3. View

Gilkeson G, Grudier J, Karounos D, Pisetsky D . Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol. 1989; 142(5):1482-6. View

Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H . Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol. 1989; 143(12):3949-55. View

Morris S, Cheek R, Cohen P, Eisenberg R . Autoantibodies in chronic graft versus host result from cognate T-B interactions. J Exp Med. 1990; 171(2):503-17. PMC: 2187721. DOI: 10.1084/jem.171.2.503. View

Dziarski R . Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. I. In vitro studies. J Immunol. 1982; 128(3):1018-25. View

10.

Nordan R, Potter M . A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science. 1986; 233(4763):566-9. DOI: 10.1126/science.3726549. View

11.

Jourdan M, Bataille R, Seguin J, Zhang X, Chaptal P, Klein B . Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. Arthritis Rheum. 1990; 33(3):398-402. DOI: 10.1002/art.1780330313. View

12.

Vink A, Coulie P, Warnier G, Renauld J, Stevens M, Donckers D . Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor. J Exp Med. 1990; 172(3):997-1000. PMC: 2188547. DOI: 10.1084/jem.172.3.997. View

13.

Mihara M, Fukui H, Koishihara Y, Saito M, Ohsugi Y . Immunologic abnormality in NZB/W F1 mice. Thymus-independent expansion of B cells responding to interleukin-6. Clin Exp Immunol. 1990; 82(3):533-7. PMC: 1535487. DOI: 10.1111/j.1365-2249.1990.tb05485.x. View

14.

Tang B, Matsuda T, Akira S, Nagata N, Ikehara S, Hirano T . Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol. 1991; 3(3):273-8. DOI: 10.1093/intimm/3.3.273. View

15.

Muller M, Emmendorffer A, Lohmann-Matthes M . Expansion and high proliferative potential of the macrophage system throughout life time of lupus-prone NZB/W and MRL lpr/lpr mice. Lack of down-regulation of extramedullar macrophage proliferation in the postnatal period. Eur J Immunol. 1991; 21(9):2211-7. DOI: 10.1002/eji.1830210932. View

16.

Shacter E, Arzadon G, Williams J . Elevation of interleukin-6 in response to a chronic inflammatory stimulus in mice: inhibition by indomethacin. Blood. 1992; 80(1):194-202. View

17.

Alarcon-Riquelme M, Moller G, Fernandez C . Macrophage depletion decreases IgG anti-DNA in cultures from (NZB x NZW)F1 spleen cells by eliminating the main source of IL-6. Clin Exp Immunol. 1993; 91(2):220-5. PMC: 1554691. DOI: 10.1111/j.1365-2249.1993.tb05886.x. View

18.

Kobayashi I, Matsuda T, Saito T, Yasukawa K, Kikutani H, Hirano T . Abnormal distribution of IL-6 receptor in aged MRL/lpr mice: elevated expression on B cells and absence on CD4+ cells. Int Immunol. 1992; 4(12):1407-12. DOI: 10.1093/intimm/4.12.1407. View

19.

Bloom D, Davignon J, Cohen P, Eisenberg R, Clarke S . Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. J Immunol. 1993; 150(4):1579-90. View

20.

Mohan C, Adams S, Stanik V, Datta S . Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993; 177(5):1367-81. PMC: 2191002. DOI: 10.1084/jem.177.5.1367. View